Sanofi (SNYNF)
OTCMKTS
· Delayed Price · Currency is USD
110.33
0.00 (0.00%)
Mar 31, 2025, 4:00 PM EST
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
$553,216
Profits / Employee
$69,455
Market Cap
134.84B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | 99,412 | -997 | -0.99% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| Silence Therapeutics | 116 |
| American Oncology Network | 1,525 |
Sanofi News
- 3 days ago - Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors - GlobeNewsWire
- 3 days ago - Sanofi gets FDA nod for its hemophilia treatment - Seeking Alpha
- 3 days ago - US FDA approves Sanofi's bleeding disorder therapy - Reuters
- 3 days ago - AbbVie Vs. Sanofi: Which Is The Better Investment Right Now - Seeking Alpha
- 4 days ago - Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD - GlobeNewsWire
- 5 days ago - Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate - Fortune
- 6 days ago - Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA - GlobeNewsWire
- 6 days ago - Sanofi gets priority review for its multiple sclerosis treatment by FDA - Seeking Alpha